Protalix BioTherapeutics (AMEX:PLX) 報告透露每股收益爲$0.04，超過分析師的預期$0.01 300%。與去年同期每股收益$0.09相比下降了55.56%。公司報告季度銷售額爲$53.40百萬，低於分析師預期的$53.94百萬，差距爲1.01%。相比去年同期銷售額$65.49百萬下降了18.47%。

以上內容來自Benzinga Earnings專欄，原文如下：

Protalix BioTherapeutics (AMEX:PLX) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. This is a 55.56 percent decrease over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $53.40 million which missed the analyst consensus estimate of $53.94 million by 1.01 percent. This is a 18.47 percent decrease over sales of $65.49 million the same period last year.